Arcara Jeffrey (0002010430)

Mailing Address C/O CORVUS PHARMACEUTICALS, INC. 863 MITTEN ROAD, SUITE 102 BURLINGAME CA 94010 Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.) Issuer Filings Transaction Date Type of Owner Corvus Pharmaceuticals, Inc. 0001626971 2024-02-02 officer: Chief Business Officer

Items 1 - 3

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition	Transaction Date	Deemed Execution Date	Issuer	Form	Transaction Type	Direct or Indirect Ownership	Number of Securities Transacted	Number of Securities Owned	Line Number	Issuer CIK	Security Name
A	2024-12-20		Corvus Pharmaceuticals, Inc.	4	A-Award	--D	50000.0000	50000.0000	1	0001626971	Stock Option (Right to Buy)
A	2024-02-28		Corvus Pharmaceuticals, Inc.	4	A-Award	--D	400000.0000	400000.0000	1	0001626971	Stock Option (Right to Buy)
-	-		Corvus Pharmaceuticals, Inc.	3	-	---			1	-	-

http://www.sec.gov/cgi-bin/own-disp

---